CTI Experts Discuss Cell and Gene Therapy

Episode 4 assembles various CTI experts to discuss Cell and Gene Therapy. In episode 4, Bret Marshall, joins us to discuss CTI’s involvement in Cardiac Cell and Gene trials, our impact, and goals, as well as the current industry trends and advocacy groups. Jaclyn Guillory discussed the groundbreaking advancements in targeted therapies for KRAS mutations. Later in the episode, Michael Schmidt and Nicole Sparshott joined to discuss cell product chain of custody. Concluding with Joana Lancastre’s discussion on feasibility in cell and gene therapy.